Vana I Spoulou - Infectious Diseases

Author Information

Vana I Spoulou is affiliated with the First Department of Paediatrics at the "Aghia Sophia" Children's Hospital, Immunobiology Research Laboratory, and Infectious Diseases Department "MAKKA" at Athens Medical School, located in Athens, Greece. Her work primarily focuses on pediatric infectious diseases, with significant contributions to understanding and treating conditions related to respiratory infections and immunological responses in children.

Research Contributions

Vana I Spoulou has made substantial contributions in the field of infectious diseases, particularly concerning pediatric populations. Her recent work includes studies on COVID-19, such as investigating pulmonary embolism in adolescents with COVID-19, and the prevalence of SARS-CoV-2 antibodies among healthcare workers in pediatric facilities. Additionally, she has contributed to research on pneumococcal immunization strategies for high-risk pediatric populations and the development of serotype-independent pneumococcal vaccines. Her research also delves into the molecular testing of SARS-CoV-2 in hospital pediatric departments and the clinical characteristics of COVID-19 in neonates and young infants.

Aliases

Vana I Spoulou is also known by several aliases in scientific literature, including V Spoulou, V. Spoulou, and Vana Spoulou. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	61
Total Citations	931
H-index	18

Publications:

Pulmonary embolism in adolescent with COVID-19 during aromatase inhibitor therapy.

DOI: 10.1002/ppul.25944

Year: 2022

Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries

DOI: 10.1016/j.jhin.2020.12.019

Year: 2021

SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study

DOI: 10.1017/S0950268821000455

Year: 2021

Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study

DOI: 10.1136/bmjresp-2021-000887

Year: 2021

Clinical characteristics of COVID-19 in neonates and young infants

DOI: 10.1007/s00431-021-04042-x

Year: 2021

Case Report: A Novel Synonymous ARPC1B Gene Mutation Causes a Syndrome of Combined Immunodeficiency, Asthma, and Allergy With Significant Intrafamilial Clinical Heterogeneity

DOI: 10.3389/fimmu.2021.634313

Year: 2021

Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers

DOI: 10.3390/diagnostics11111970

Year: 2021

Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review

DOI: 10.3389/fonc.2021.687631

Year: 2021

Pneumococcal Immunization Strategies for High-Risk Pediatric Populations Worldwide: One Size Does Not Fit All

DOI: 10.3390/vaccines9121390

Year: 2021

Understanding host immune responses to pneumococcal proteins in the upper respiratory tract to develop serotype-independent pneumococcal vaccines

DOI: 10.1080/14760584.2020.1843433

Year: 2020

How does ELISA work?

How Can We Promote Condom Use?

How Does Glycolysis Relate to Infectious Diseases?

What is the Inflammatory Response?

How Are Muscle Aches Diagnosed?

What is Parasite DNA?

What is the Treatment for E. Coli Infection?

What are the Challenges in Malaria Control?

What are the Symptoms of Salmonella Infection?

How Can We Improve Global Health Infrastructure to Combat Infectious Diseases?

Partnered Content Networks

Relevant Topics